Navigation Links
Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot
Date:3/19/2009

Body shaping (through circumferential reduction) treatment by Syneron(TM) exposed as celebrity beauty secret

IRVINE, Calif., March 19 /PRNewswire/ -- Khloe Kardashian, celebrity and star of the E! show Keeping up with the Kardashians, receives the VelaShape(TM) (http://velashape.com) treatment for cellulite reduction and body contouring through circumferential reduction during the March 22 episode airing at 10/9c.

In the episode, Khloe prepares her body for an upcoming photo shoot for a charity ad campaign. Khloe visits Dr. Shalini Kapoor-Grover of REVIVE: Beverly Hills Medical Institute and receives VelaShape treatments on her stomach.

VelaShape, clinically proven to take inches off the thighs, is a celebrity beauty secret that has been embraced by not only Khloe but also her sister, Kim Kardashian.

"For women already in great shape, like Khloe Kardashian, VelaShape helps smooth and contour curves," said Dr. Shalini. "My VelaShape patients include men and women looking to not only smooth the top layer of the skin but also to even out stubborn pockets of fat on the thighs, buttocks, stomach, back and arms that are not reduced with diet and exercise alone."

VelaShape, developed by Syneron(TM) Medical Ltd. (Nasdaq: ELOS), tightens and tones flabby skin through heat, vacuum and massage to reduce or shrink the size of the actual fat cells and fat chambers. In four to six treatments, each spaced one week apart, the non-invasive VelaShape dramatically improves the appearance of problem areas including the arms, love handles, buttocks, stomach and thighs.

In a recent poll of 195 VelaShape treatment providers, more than 84 percent reported VelaShape resulted in an average circumferential reduction of one to two inches, 14 percent reported an average of two to four inches and two percent reported an average reduction of five inches or more.

To find a VelaShape treatment provider near you or for more information, please visit http://www.velashape.com. Catch new episodes of Keeping up with the Kardashians Sundays at 10/9c.

About Syneron

Syneron Medical Ltd. (Nasdaq: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, cellulite, circumferential reduction and the treatment of acne, leg veins and laser-assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, California, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at http://www.syneron.com.

Syneron, the Syneron logo, VelaShape and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

    For more information, please contact:

    Angela Leon, Airfoil PR for Syneron
    248-304-1445
    leon@airfoilpr.com


'/>"/>
SOURCE Syneron Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
Breaking Medicine Technology: